Drawing for Serial No. 99117649

USPTO serial 99117649

Serial No. 99117649

Reviewed by CopyMark Law Group

Status 819
Filing date
Status date
Registration date
—
Examiner
PLOUFF, ABIGAIL M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 99117649?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cheryl Foytlin

Cheryl Foytlin Johnson & JohnsonOne Johnson & Johnson PlazaNew Brunswick, NJ 08933United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disordersACTIVEMar 18, 2026
044Providing information in the field of treatment and prevention of autoimmune diseases and disordersACTIVEMar 18, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 2, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 30, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 29, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 29, 2026EX2GSOU EXTENSION 2 GRANTED—
Jul 29, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 26, 2026IUAFUSE AMENDMENT FILED—
May 26, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 26, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 25, 2026EXT2SOU EXTENSION 2 FILED—
Dec 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2025EX1GSOU EXTENSION 1 GRANTED—
Dec 17, 2025EXT1SOU EXTENSION 1 FILED—
Dec 17, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 22, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 27, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 27, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 21, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 25, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2025DOCKASSIGNED TO EXAMINER—
Apr 20, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 20, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 2, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance